Cytomegalovirus (CMV) DNA by Molecular, Qualitative or Quantitative
Celiac Disease Antibody Panel
Protein C, Total Antigen
Pregnancy Associated Plasma Protein-A (PAPP-A)
Giardia lamblia Antibody, IgG, IgA, IgM, IFA
Mismatch Repair (MMR) Protein, Immunohistochemistry
Monkeypox Virus DNA by PCR
Ganglioside (GM1) Antibody, IgG and IgM
Melanoma Gene Mutation Panel, NGS
Aspergillus DNA, Qualitative, Real-Time PCR, CSF
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
Clinical Utility
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...